Selecting SSRIs for Geriatric Patients

Dosing and Administration

The American Academy of Family Physicians recommends a starting dose of 25-50 mg per day of sertraline for geriatric patients 1
The maximum dose of sertraline for geriatric patients is 200 mg per day, which can be taken in the morning or evening 1
Citalopram is an alternative SSRI option, with a starting dose of 10 mg per day 1

Escitalopram is a preferred agent for older patients with depression, with a lower risk of drug interactions than many other antidepressants 2
Escitalopram has a lower risk of drug interactions than many other antidepressants, but monitoring for QT prolongation is recommended, especially at higher doses 3

Paroxetine should generally be avoided in older adults due to higher rates of adverse effects, including more anticholinergic effects than other SSRIs 1
Fluoxetine should generally be avoided in older adults due to higher rates of adverse effects, including a very long half-life and activating properties that may be problematic in anxious elderly patients 1

All SSRIs can cause common side effects such as sweating, tremors, nervousness, insomnia or somnolence, dizziness, gastrointestinal disturbances, and sexual dysfunction 1
Monitoring for hyponatremia is recommended, as it occurs in 0.5% to 12% of older adults taking SSRIs 3
There is a risk of gastrointestinal bleeding, especially with concurrent use of NSAIDs or antiplatelet drugs 3

The "start low, go slow" approach should be followed to minimize adverse effects in geriatric patients 2
Treatment for a first episode of major depression should last at least four months 2
Patients with recurrent depression may benefit from prolonged treatment 2

Escitalopram (10-20 mg/day) is another preferred option for elderly patients with anxiety, as recommended by the American Academy of Family Physicians 4
Citalopram (starting at 10 mg/day) is also considered appropriate for elderly patients with anxiety 4
Paroxetine should generally be avoided in older adults due to higher rates of anticholinergic effects, according to the American Academy of Family Physicians 4
Fluoxetine should generally be avoided in elderly patients due to its very long half-life and greater risk of agitation and overstimulation, as noted by the American Academy of Family Physicians 4
Treatment for a first episode of anxiety should last at least 4-12 months, as recommended by the American Academy of Family Physicians 4
Antidepressants are most effective in patients with severe symptoms, as reported by the American Academy of Family Physicians 5

The American College of Physicians and other guideline societies suggest that efficacy is equivalent to other SSRIs in patients ≥65 years, including those ≥80 years, with sertraline being a preferred option 6, 7
The American Geriatrics Society notes that SSRIs increase fracture risk through effects on osteoblast activity, with the risk more than doubling with long-term use, particularly concerning in elderly females with osteoporosis risk 8
The European Society of Cardiology recommends monitoring for bleeding risk, particularly with concurrent NSAIDs or antiplatelet drugs, given cardiovascular disease prevalence in this age group 9
The American College of Cardiology and other organizations acknowledge that concurrent clopidogrel and SSRIs (especially escitalopram) can increase bleeding risk, and proton pump inhibitors may decrease clopidogrel effectiveness when combined with SSRIs 8